Candriam S.C.A. Sangamo Therapeutics, Inc Transaction History

Candriam S.C.A.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$1.66 - $3.67 $336,438 - $743,813	202,674 New	202,674 $356,000
Q4 2020 Jan 22, 2021	SELL	$9.23 - $18.18 $3.42 Million - $6.73 Million	-370,000 Closed	0 $0
Q2 2020 Jul 23, 2020	SELL	$6.21 - $11.83 $931,500 - $1.77 Million	-150,000 Reduced 28.85%	370,000 $3.32 Million
Q4 2019 Jan 21, 2020	SELL	$8.03 - $11.7 $762,849 - $1.11 Million	-95,000 Reduced 15.45%	520,000 $4,000
Q3 2019 Oct 21, 2019	BUY	$9.05 - $12.22 $1.81 Million - $2.44 Million	200,000 Added 48.19%	615,000 $6,000
Q2 2019 Aug 01, 2019	BUY	$8.75 - $13.03 $3.63 Million - $5.41 Million	415,000 New	415,000 $4.45 Million

111

56.7M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $193M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.